A Study to Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years

NCT04450498 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
260
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Walvax Biotechnology Co., Ltd.